Table 2

Cost analysis of three projects showing a cumulative savings of $326 974 over 2 years

TotalQ1 2013Q2 2013Q3 2013Q4 2013Q1 2014Q2 2014Q3 2014Q4 2014
Total $Cost/Test−$326 974−$8536−$9967−$29 471−$47 352−$58 205−$53 910−$66 713−$52 819
Cr #−1594−198−281−266−219−189−149−128−165
BUN #−1581−204−285−273−207−197−151−120−145
BUN + Cr $$1−$3175−$401−$565−$539−$426−$386−$300−$248−$309
DXA #−435−40−46−39−49−47−72−70−71
DXA $$203−$88 348−$8135−$9402−$7919−$10 040−$9584−$14 607−$14 188−$14 473
CXR #−1428−120−210−275−222−298−217
CXR $ $176−$235 450−$21 013−$36 886−$48 236−$39 002−$52 277−$38 037
  • Rows # denotes the number of tests reduced from baseline over the measured period. Rows with a $ is the cost avoided in revenue if an outpatient procedure or direct cost if performed as an inpatient. This figure is taken by multiplying the number of tests saved by the cost per test. Cost savings are a conservative estimate, which do not include projects still acquiring postintervention data or other downstream costs avoided due to changes in ordering practices.

  • DXA, dual-energy X-ray absorptiometry.